Bryan John Magoling is addressing the global issue of breast cancer, which poses a significant threat to women’s lives. His research involves using a genetic reporter called PalmGRET to label and track extracellular vesicles (EVs) in the body, revealing that EVs released by cancers promote tumor growth. By modifying the surface proteins of these EVs, their pro-tumorigenic activities can be reduced, potentially offering insights for precise diagnostics and cancer therapies.
Falling Walls
Falling Walls Science Summit 2023
Login or Register
You need to be logged in to use this feature.
Breaking the Wall of Cancers’ “Trojan Horse”
Bryan John Magoling received his PhD degree in biochemical sciences from the National Taiwan University, where he studied the roles of extracellular vesicles (EVs) in the progression of breast cancer in Dr Lai’s lab. He is a chemist by training with research experience in the development of diagnostic imaging tools and drug delivery systems. With his training in the fields of chemistry and molecular biology, he is working to elucidate the biological properties of cancer-derived EVs. Furthermore, he is highly motivated to translate these key findings into the development of EV-mediated diagnostics and therapies for precision healthcare.
Further Activities to have a look at